A PIPELINE POWERED BYPASSION
PUBLICATIONS AND PRESENTATIONS
Effects of Aficamten on cardiac contractility in a feline translational model of hypertrophic cardiomyopathy
Scientific Reports
Sharpe AN, et al
January 2, 2023
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology
Maron MS, et al
January 3, 2023
ENCALS Predictive Survival Model in FORTITUDE-ALS
Poster, 33rd International Symposium on ALS/MND
Simkins T, et al
Virtual
December 8, 2022
Costs and Healthcare Resource Utilization for Obstructive Hypertrophic Cardiomyopathy With Septal Reduction Therapy
Journal of Invasive Cardiology
Butzner, M, et al
December 2022
Pharmacokinetics of a Single Dose of Aficamten (CK-274) on Cardiac Contractility in a A31P MYBPC3 Hypertrophic Cardiomyopathy Cat Model
Journal of Veterinary Pharmacology & Therapeutics
Sharpe, AN, et al
November 16, 2022